European Archives - Page 1103 of 1195 - European Medical Journal

EMJ

Reducing prostate cancer progression and mortality: what patients can do to reduce risk

Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…

EMJ

Helping healthcare professionals initiate conversations about physical activity

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…

EMJ

Two New Analyses Show Cost Effectiveness of Rifaximin-α 550mg Treatment in Belgian and Dutch Patients with Recurrent Hepatic Encephalopathy

LONDON, UK, Thursday 19 November, 07.00 GMT: Norgine B.V. has presented new analyses demonstrating the cost effectiveness of XIFAXAN® / TARGAXAN® 550…

EMJ

Keeping active with Macmillan Cancer Support

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer Support initiative aimed…

EMJ

Physical activity – the panacea?

Robert Thomas, MbChb, MRCP, MD, FRCR, gives an overview of the session “Physical activity – the panacea?” at the 2015 National Cancer Research Institute…

EMJ

The development of genomic tests and how validation affects their use in the clinic

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…

EMJ

2015 NCRI Cancer Conference: Francis Crick Institute scientists

Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses topics covered…

EMJ

Clonal evolution in colorectal cancer

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Alberto Bardelli, PhD talks about clonal evolution in colorectal cancer. He also…

EMJ

Update on CheckMate 067, an advanced melanoma clinical trial

James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…

EMJ

Physical activity levels and barriers to exercise referral among patients with cancer

Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…